Spurred by a teacher who has seen the issues wrought by substance use among local teens, the proposal hinges on getting funding from the state’s pool of opioid settlement money.

A growing number of treatment centers, with mergers with private recovery institutions to aid in the extension of treatment access to a wide range of people is expected to push market growth. Moreover ...

At issue: whether opioid settlement money — paid by health care companies that were sued for fueling the opioid crisis and meant to help states abate addiction — should be funneled to two ...

Individuals receiving buprenorphine treatment for opioid use disorder and who have residual craving benefit from mindfulness training.

Most people understand that our country is facing a crisis of opioid addiction and deaths. To combat this, you need proven solutions and resources. Yet, a lot of the money that is supposed to be ...

Stay updated with a weekly recap covering market movements, economic insights, top news, and geopolitical events shaping the ...

TUESDAY, Feb. 25, 2025 (HealthDay News) -- More emergency room doctors in California are prescribing the anti-addiction ...

BTB Therapeutics, Inc., a clinical-stage drug development company developing a non-opioid pain medicine ENDOPIN, today announced the election of David R. Snyder, Esq. and Nobuhiro Yagi, PhD to its ...

Cencora offers steady revenue growth from pharmaceutical distribution, benefiting from rising healthcare demand and an aging ...

They will be instrumental as we advance our pipeline of first-in-class non-opioid analgesic compound, ENDOPIN,” said Takashi Kiyoizumi, MD, PhD, CEO of BTB Therapeutics. “I am honored to join ...

Endo's slide into bankruptcy follows in the footsteps of Purdue Pharma – which filed in 2019 but is still negotiating opioid settlement and corporate restructuring terms – as well as ...

Buspirone can interact with other drugs, including antidepressants, monoamine oxidase inhibitors, opioids, and more.